Navigation Links
GP targets on heart disease should be simpler and based more on treatment and prevention
Date:9/14/2007

GP performance related payments for tackling heart disease are too complex. They should be simplified and based more on disease treatment and prevention and less on risk factor measurement, experts advise in this weeks BMJ.

General practice in the United Kingdom has the largest healthcare pay for performance programme in the world the quality and outcomes framework (QOF). Practices earn points for the services they provide and these points attract financial resources into the practice.

Professor Bruce Guthrie and colleagues discuss the effectiveness of the system in relation to the management of cardiovascular disease and show how practices can earn many points and extra payments without necessarily reducing its risk.

For example, a practice could receive nine points (each worth about 125) for generating a list of patients with high blood pressure. An extra 30 points would be earned if 90% or more of such patients have a record of risk factors (blood pressure and smoking history) in their notes, and 56 more points would be earned if 70% or more of such patients have a record of blood pressure lowered to below specific target values.

Overall, 15% of payments, worth an estimated 200m across the approximate 11,000 general practices in the UK, arise from measuring cardiovascular risk factors (such as blood pressure and cholesterol) and recording whether they are below specified values.

They reason that its time to incorporate treatment information into quality indicators, since it is the treatment of risk factors that reduces risk, not their measurement.

Meeting current targets for cardiovascular disease does not guarantee good management, they warn. Treatment information would clearly identify opportunities for intervention and improved patient care.

These views are supported by Consultant Cardiologist, David Wald, in an accompanying editorial. He believes that the treatment and prevention of cardiovascular disease is becoming a series of isolated tasks predicated on financial rather than clinical value, and argues that many of the QOF measurements relating to cardiovascular disease achieve little.

The QOF has been useful in drawing attention to the importance of the treatment and prevention of cardiovascular disease, but not how best to do so, he says.

He suggests simplifying the system so that payments are directly linked to treatment and prevention rather than the process, while protecting the independent professional status of doctors in the UK.


'/>"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
Source:Eurekalert

Related medicine news :

1. Scios Inc. targets drug giants in arthritis war
2. Research Targets treatment for dementia and brain injuries
3. Cancer Treatments Fall Short Of Targets
4. India Targets Eliminating Leprosy
5. Study Would Pave Way for the Development of New Drugs That Targets TB Proteasome
6. Health Targets To Treat Cancer Patients Unlikely To Be Met
7. "Super Drug" Targets Disease-Causing Gene
8. Queensland Government to Meet its Medical Targets
9. No Clear Evidence for Ultra-Low Cholesterol Targets?
10. Health Minister Stresses the Importance of Realistic Health Targets
11. NIDs Targets Immunizations To 22 Million Children In Bangladesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... of ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and ... may have been used to remove decayed dental matter, and that teeth were then ...
(Date:4/21/2017)... ... 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD ... a benign bony lump located on the forehead usually attributed to a facial fracture. ... and pain. Dr. Shah has discovered an approach that is minimally invasive. He is ...
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility ... Hong Kong to support teaching, learning and research. It is also the largest research ... Hong Kong. , With an area of 620 square metres and more than ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway Management, the medical device ... highly regarded and well renowned Asian distributor, Discovery Sleep. The agreement ... Pillow Mask, and will stabilize and strengthen Airway’s presence with a dedicated, reputable ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of ... Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ... ... at US$ 7,167.6 Mn in 2015, and is expected to ... of 5.6% from 2016 to 2024. The ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: